BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3495523)

  • 1. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.
    Nunez G; Ball EJ; Stastny P
    Hum Immunol; 1987 May; 19(1):29-39. PubMed ID: 3495523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of class II antigens by subsets of activated T cells.
    Zier KS
    Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both HLA-DR and HLA-DQ determinants contribute to HLA-Dw typing.
    Sterkers G; Zeliszewski D; Freidel AC; Gebuhrer L; Betuel H; Levy JP
    Hum Immunol; 1987 Nov; 20(3):233-47. PubMed ID: 2449409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
    Linner KM; Monroy C; Bach FH; Gehrz RC
    Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
    Brooks CF; Moore M
    Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
    Matsuoka T; Tabata H; Matsushita S
    J Immunol; 2001 Feb; 166(4):2202-8. PubMed ID: 11160273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional roles of human class II antigens in T cell proliferative response. Comparison of the DR and DQ molecules using mouse monoclonal antibodies.
    Chen RF; Maeda H
    J Immunogenet; 1986; 13(5-6):401-13. PubMed ID: 3497988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells.
    Zeliszewski D; Sterkers G; Brautbar C; Betuel H; Layrisse Z; Levy JP
    Immunogenetics; 1987; 26(1-2):107-10. PubMed ID: 3497098
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Chen BP; DeMars R; Sondel PM
    Hum Immunol; 1987 Jan; 18(1):75-91. PubMed ID: 3542914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.
    Michon J; Henin Y; Sterkers G; Freidel C; Gebuhrer L; Betuel H; Muller JY; Levy JP
    Immunogenetics; 1986; 24(3):177-83. PubMed ID: 2428744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules.
    Gjertsen HA; Sollid LM; Ek J; Thorsby E; Lundin KE
    Scand J Immunol; 1994 Jun; 39(6):567-74. PubMed ID: 8009173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.